首页> 美国卫生研究院文献>other >A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab with Daily Irradiation or Paclitaxel Alone with Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates with Muscle-Invasive Bladder Cancer (Trial ****)

【2h】

A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab with Daily Irradiation or Paclitaxel Alone with Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates with Muscle-Invasive Bladder Cancer (Trial ****)

机译：非膀胱切除术伴有膀胱浸润性膀胱癌的经尿道手术后紫杉醇和曲妥珠单抗联合每日放疗或单独紫杉醇联合每日放疗的I / II期试验（试验****）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 other
作者
M. Dror Michaelson; Chen Hu; Huong T. Pham; Douglas M. Dahl; Chin Lee-Wu; Gregory P. Swanson; Jacqueline Vuky; R. Jeffrey Lee; Luis Souhami; Brian Chang; Asha George; Howard Sandler; William Shipley;
展开▼
作者单位

展开▼
年(卷),期 -1(97),5
年度 -1
页码 995–1001
总页数 17
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 0524) [J] . Michaelson M. Dror, Hu Chen, Pham Huong T., International Journal of Radiation Oncology, Biology, Physics . 2017,第5期

机译：紫杉醇和曲妥珠单抗组合的阶段1/2试验与日常辐射或紫杉醇单独进行每日辐照，用于肌肉侵入性膀胱癌的非胞间切除术候选后的每日辐照（试验NRG肿瘤0524）
2. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy. [J] . Kaufman DS, Winter KA, Shipley WU, Urology . 2009,第4期

机译：ITO II期RTOG研究（99-06）是接受经尿道手术，紫杉醇，顺铂和每日两次放射疗法，然后进行选择性膀胱保留或根治性膀胱切除术和辅助化疗的肌肉浸润性膀胱癌患者。
3. Re: Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): A randomised multicentre phase 2 trial [J] . VanDerPoelH. European urology . 2014,第6期

机译：回复：经尿道手术和每日两次放射联合紫杉醇-顺铂或氟尿嘧啶-顺铂联合选择性膀胱保存和辅助化学疗法治疗肌肉浸润性膀胱癌（RTOG 0233）：一项随机的多中心2期试验
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. Clinical predictive value of pre-clinical cancer models: A study of the predictive value of the in vitro cell line, human xenograft and murine allograft pre-clinical cancer models for phase II clinical trials of cytotoxic cancer drugs [D] . Voskoglou-Nomikos, Theodora 2001

机译：临床前癌症模型的临床预测价值：体外细胞系，人异种移植和小鼠同种异体移植临床前癌症模型对细胞毒性癌症药物II期临床试验的预测价值研究
6. Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial [O] . Timur Mitin, Daniel Hunt, William U Shipley, -1

机译：经尿道手术和每日两次放射联合紫杉醇-顺铂或氟尿嘧啶-顺铂联合选择性膀胱保存和辅助化学疗法治疗肌肉浸润性膀胱癌的患者（RTOG 0233）：一项随机的多中心2期临床试验
7. A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 0524) [O] . M. Dror Michaelson, Chen Hu, Huong T. Pham, 2017

机译：紫杉醇和曲妥珠单抗组合的阶段1/2试验与日常辐射或紫杉醇单独进行每日辐照，用于肌肉侵入性膀胱癌的非胞间切除术候选后的每日辐照（试验NRG肿瘤0524）

A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab with Daily Irradiation or Paclitaxel Alone with Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates with Muscle-Invasive Bladder Cancer (Trial ****)

著录项

相似文献

相关主题

期刊订阅